Paulo Jorge Pereira

As Vice President of Business Development for Europe, I am responsible for driving our expansion and establishing key partnerships across the continent. My focus includes securing new customers and nurturing relationships that support the company's visibility and healthy lead generation. Key Responsibilities • Developing and negotiating new contracts • Managing existing contracts • Overseeing the quoting process • Building strategic partnerships and ecosystems to enhance market presence About JYMedtech At JYMedtech, we specialise in peptide-focused research and development as well as GMP API production. Our facilities feature ten cGMP production lines and a 30,000 L SPPS/LPPS reactor volume. Sites are inspected by both the FDA and NMPA, allowing us to scale projects from milligrams to multi-kilogram batches for therapeutic, cosmetic, and specialty applications. With strong scientific expertise, advanced facilities, and a dedication to regulatory standards, JYMedtech serves as a strategic partner for peptides, APIs, and CDMO services. From concept through to commercialisation, we deliver precision, efficiency, and compliance at every stage.

Pfizer CentreOne (PC1) is a global contract development and manufacturing organization (CDMO) embedded within Pfizer. PC1 leverage strategic Pfizer manufacturing plants as well as science and technology resources to manufacture medicine for biopharmaceutical companies. PC1 focus on custom API synthesis, sterile injectable fill-finish and highly potent oral solid dose; and are a leading supplier of steroid and hormone APIs and intermediates. For almost 50 years, we’ve manufactured complex compounds for our biopharmaceutical partners. The Global account Director (API&I and CDMO Business) is responsible for driving new business, while maintaining and expanding established relationships with numerous large biopharmaceutical companies.

The Deal Sourcing and Evaluation team, operating within the PEH CBO, is responsible for identifying ways to build on the PEH P&L. The group will develop and execute a business development and partnership strategy for PEH in line with PEH global strategic objectives. Execution of the plan will involve sourcing and prioritizing business development and strategic partnership opportunities and then leading the commercial assessments and overall business case development cross-functionally.

PEH Europe is a large and complex region responsible for $6.0B in revenue generated across several hundred products in more than 50 markets, including Emerging Europe. Regional Director of New Business Planning is responsible to support the robust and efficient evaluation and assessment of regional growth projects in those markets. Focus areas:  Business Development  Organic (cross-pollination, line-extension, product enhancements)  Other strategic projects as identified by regional leadership

GEP Europe is a large and complex region responsible for $6.0B in revenue generated across several hundred products in more than 50 markets, including Emerging Europe. New Business Planning senior Manager is responsible to support the robust and efficient evaluation and assessment of regional growth projects in those markets. Main Responsibilities:  Coordinates efforts to identify and evaluate new business growth opportunities at the country and regional levels, including partnerships, cross-pollinations, product enhancements, acquisitions and other growth transactions.  Supports development and execution of GEP Europe business development and growth strategy.  Collaborates with global and regional Business Development, Business Alliance, and enabling function to support the business case development across markets, and support project through decision and governance process within GEP BU and within the corporate context.  Collaborates with New business planning team, partner lines and market colleagues to develop, review, and assess business cases for organic growth projects  Capture learnings and translate to best practices/guidance for conducting commercial assessments including right tools/templates as well as training & capability development  Ensure compliance with global and regional governance process.  Manage commercial assessments for in-organic growth projects and ensure proper governance and due diligence.

Paulo Pereira is the Retail & Hospital Lead in Global Established Pharma at Pfizer Portugal. Paulo is responsible for all commercial strategy, Wholesalers, Pharmacies, Hospitals and Tenders. Prior to this role, Paulo was Commercial Manager and National Sales Manager at EPBU. Prior to the BU’s structure, served as Mature Products project lead – a pilot project that preceded EP BU Birth in Portugal and worldwide. During his tenure in EPBU, Paulo had important achievements: defining strategies for pharmacy channel; developing different pharmacy campaigns through field force, wholesalers and call centre; the switch of some products to OTC status; commercial coordination of the launch of Pfizer Portugal Gx line (Parke-Davis).Moreover, Paulo lead a structural and strategic change in the hospital and pharmacy field forces from sales reps to Key Accounts developing new concepts and skills to the different functions. Since 2008, he also leads tenders process and is responsible for the BU’s top line. Paulo owns a post-graduation in management from AESE/IESE business school (the most valued business school in Portugal and Spain) where he has acquired specialization on Finance, Marketing, People, Operations and Accounting. He has 17 years of experience, the last 12 at Pfizer where he started in 2001 as a sales rep.

Wholesalers. Built contact network on all major wholesalers, from the regular contact with purchase managers up to strategic negotiations with country managers Hospital Negotiation. Analysis of optimal pricing, competitive intelligence tracking, engage with hospital administrations for win-win partnerships, and tenders. Sales team with two Hospital Key accounts Government tenders Relationship government entity (SPMS) that allows products to be introduced in the approved catalogue that hospitals can buy from (ACSS). Pharmacy Sales Sales team management Lead a structural and strategic change from sales reps to Pharmacy Key Accounts applying the “The art of KAM” and the Diamond concept Volume and Revenue forecast Forecast of all products of the Business Unit (80 in total)